首页> 外文期刊>Frontiers in Immunology >Isoliquiritigenin Activates Nuclear Factor Erythroid-2 Related Factor 2 to Suppress the NOD-Like Receptor Protein 3 Inflammasome and Inhibits the NF-κB Pathway in Macrophages and in Acute Lung Injury
【24h】

Isoliquiritigenin Activates Nuclear Factor Erythroid-2 Related Factor 2 to Suppress the NOD-Like Receptor Protein 3 Inflammasome and Inhibits the NF-κB Pathway in Macrophages and in Acute Lung Injury

机译:异寡糖原蛋白激活核因子Erythroid-2相关因子2以抑制NOD样受体蛋白3炎性小体并抑制巨噬细胞和急性肺损伤中的NF-κB途径。

获取原文
           

摘要

Among the cellular response mechanisms, the nuclear factor erythroid-2 related factor 2 (Nrf2) pathway is considered a survival pathway that alleviates oxidative injury, while both the NOD-like receptor protein 3 (NLRP3) and NF-κB pathways are pro-inflammatory pathways that cause damage to cells. These pathways are implicated in the development and resolution of acute lung injury (ALI). Isoliquiritigenin (ISL), a flavonoid from the liquorice compound, is suggested to be a regulator of the above pathways, but the mechanisms of how the NLRP3/NF-κB pathway interacts with Nrf2 and its protective effects in ALI remain unknown. In the present study, ISL inhibited reactive oxygen species (ROS) generation and cytotoxicity induced by t-BHP and pro-inflammatory enzymes production induced by LPS in RAW 264.7 cells. Such cytoprotective effects coincided with the induction of AMP-activated protein kinase (AMPK)/Nrf2/antioxidant response element (ARE) signaling and the suppression of the NLRP3 and NF-κB pathways. Consistent with these findings, ISL treatment significantly alleviated lung injury in LPS-induced ALI mice, which was reflected by reductions in histopathological changes, pulmonary edema, and protein leakage. At the same time, the increased levels of inflammatory cell exudation and pro-inflammatory mediators, the enhanced production of ROS, myeloperoxidase, and malondialdehyde, and the depleted expression of GSH and superoxide dismutase induced by LPS were ameliorated by ISL. Furthermore, ISL notably activated AMPK/Nrf2/ARE signaling and inhibited LPS-induced NLRP3 and NF-κB activation in the lung. Moreover, although inhibition of the LPS-induced histopathological changes and ROS production were attenuated in Nrf2-deficient mice, the repression of the NLRP3 and NF-κB pathways by ISL was Nrf2-dependent and Nrf2-independent, respectively. In conclusion, our results are the first to highlight the beneficial role and relevant mechanisms of ISL in LPS-induced ALI and provide novel insight into its application.
机译:在细胞反应机制中,核因子erythroid-2相关因子2(Nrf2)途径被认为是缓解氧化损伤的生存途径,而NOD样受体蛋白3(NLRP3)和NF-κB途径均是促炎性的导致细胞损伤的途径。这些途径与急性肺损伤(ALI)的发展和消退有关。异黄酮生成素(ISL)是一种来自甘草化合物的类黄酮,被认为是上述途径的调节剂,但NLRP3 /NF-κB途径与Nrf2相互作用的机制及其在ALI中的保护作用仍然未知。在本研究中,ISL抑制了RAW 264.7细胞中由t-BHP诱导的活性氧(ROS)生成和细胞毒性,以及LPS诱导的促炎酶生成。此类细胞保护作用与AMP激活的蛋白激酶(AMPK)/ Nrf2 /抗氧化反应元件(ARE)信号的诱导以及NLRP3和NF-κB通路的抑制相吻合。与这些发现一致,ISL治疗显着减轻了LPS诱导的ALI小鼠的肺损伤,这在组织病理学变化,肺水肿和蛋白质渗漏的减少中得到了体现。同时,ISL改善了炎症细胞渗出和促炎介质的水平增加,ROS,髓过氧化物酶和丙二醛的产生增加,以及LPS诱导的GSH和超氧化物歧化酶表达减少。此外,ISL明显激活了AMPK / Nrf2 / ARE信号传导,并抑制了LPS诱导的肺中NLRP3和NF-κB的激活。此外,尽管在缺Nrf2的小鼠中LPS诱导的组织病理学改变和ROS产生的抑制作用减弱,但ISL对NLRP3和NF-κB通路的抑制作用分别是Nrf2依赖性和Nrf2依赖性。总之,我们的结果是第一个突出ISL在LPS诱导的ALI中的有益作用和相关机制,并为其应用提供了新颖的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号